Roweepra - labeled renal guidance
Renal action and limits
Levetiracetam (Roweepra), oral tablet
CrCl normalized to 1.73 m2, mL/min/1.73 m2
- Action or finding
- Use body-surface-area-adjusted CrCl to select the adult oral levetiracetam dose. Hemodialysis requires a supplemental dose after the session.
- Limits and monitoring
- Use the renal table for the exact oral product. Confirm the tablet strength and dosing interval.
- Before use
- Apply only to the stated formulation, indication and renal population.
- Product / population
- Levetiracetam (Roweepra), oral tablet
- Renal measure
- CrCl normalized to 1.73 m2, mL/min/1.73 m2
- Source revision
- DailyMed SPL version 5, posted May 26, 2025
- Retrieved
- 2026-11-07 (not the revision date)
Renal guidance: 2.5 Dosage Adjustments in Adult Patients with Renal Impairment / 8.6 Renal Impairment
Use body-surface-area-adjusted CrCl to select the adult oral levetiracetam dose. Hemodialysis requires a supplemental dose after the session. Use the renal table for the exact oral product. Confirm the tablet strength and dosing interval.
Source: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e662bf5b-c81c-4bcd-ba2e-552df95ca6f9
